A Novel Full-Length Recombinant Human Complement Factor H (CFH; GEM103) for the Treatment of Age-Related Macular Degeneration Shows Similar In Vitro Functional Activity to Native CFH.
Robyn M BiggsElisavet MakouScott LauderAndrew P HerbertPaul N BarlowSuresh K KattiPublished in: Current eye research (2022)
functional activity. These results support further study of GEM103 as a potential therapy for AMD.